BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7353775)

  • 1. [Relevance of CEA in benign breast disease (author's transl)].
    Opri F; Kirchner H; Mayfeld K
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):51-4. PubMed ID: 7353775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
    von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
    Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)].
    Wurster K; Heberling D; Rapp W
    Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937
    [No Abstract]   [Full Text] [Related]  

  • 4. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
    Wittekind C; von Kleist S; Sandritter W
    Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)].
    Opri F; Kirchner H
    Zentralbl Gynakol; 1981; 103(10):564-8. PubMed ID: 7269869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [beta2-Microglobulin in cancer patients (author's transl)].
    Daver A; Chassevent A; Bouali AB; Bertrand AF; Deroche C; Cellier P; Tuchais C; Souaille C; Maillart P; Bertrand G; Minier JF; Larra F; Agerup B
    Pathol Biol (Paris); 1978 Sep; 26(6):335-40. PubMed ID: 83577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CEA and breast neoplasms: application of a personal method for determination of CEA in the clinical study of 242 patients (author's transl)].
    Dell'anna B; Percudani M; Salvadori C
    Bull Cancer; 1979; 66(3):259-67. PubMed ID: 486732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R; Schröder G; Garbrecht M; Frahm H
    Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of carcinoembryonic antigen in tumor tissue and serum of breast cancer patients.
    Stratil P; Rejthar A; Lang BA; Kocent A; Pacovský Z; Matoska J
    Neoplasma; 1988; 35(1):69-76. PubMed ID: 3352839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA-like material in fluid from benign cysts of the breast.
    Fleisher M; Oettgen HF; Breed CN; Robbins GF; Pinsky CM; Schwartz MK
    Clin Chem; 1974; 20(1):41-2. PubMed ID: 4809471
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
    Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
    Vântu A; Bălănescu I; Stafidov N; Voiculeţ N
    Med Interne; 1982; 20(2):151-5. PubMed ID: 6181552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.